SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 61.96-3.2%Nov 3 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (14526)12/7/2004 2:50:45 PM
From: rkrw  Read Replies (2) of 52153
 
Seems a little different than duragesic switching :-)

From a trends-in-med pain issue:

<<<A New Jersey doctor said, “I’ll probably keep
using the brand because I'm used to writing Duragesic. It
depends on how easy it is to write the generic. If I need to
write ‘transdermal fentanyl,’ I probably won’t do it. If the
pharmacists let us write ‘TD,’ I may do it.>>>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News